New treatments and drug approvals

Read the latest news and views from Lymphoma Action. 

Use the drop down filter to find the most relevant news for you.

Scottish Medicines Consortium

New SMC guidance for DLBCL

The Scottish Medicines Consortium recommends loncastuximab tesirine but not axicabtagene ciloleucel as treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma.